Skip to main content
Log in

Tensioactivity and Supramolecular Organization of the Palmitoyl Prodrug of Timolol

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To improve the bioavailability of the ocular drug timolol by facilitating its transport through the cornea, an amphiphilic prodrug was synthesized via the addition of a palmitic chain by esterification. The present study was undertaken to investigate the physicochemical and tensioactive properties of the prodrug.

Methods. The amphiphilic properties of the prodrug were firstly investigated by the Wilhelmy plate method. The textures generated by the supramolecular organizations of the ester were visualized by optical microscopy.

Results. The prodrug clearly decreased the surface tension. Optical microscopy provided excellent evidence for the existence of lyotropic liquid crystalline phases: two isotropic but organized phases and a birefringent lamellar phase.

Conclusions. The results from the ensemble of studies undertaken to determine the amphiphilic properties of the prodrug were all in accord with its ability to form liquid crystalline phases. The liquid crystalline state of the prodrug is believed to introduce a delay in the drug pharmacological effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. W. L. Nelson, F. T. Fraunfelder, J. M. Sills, J. B. Arrowsmith, and J. N. Kuritsky. Am. J. Ophthalmol. 102:606–611 (1986).

    PubMed  Google Scholar 

  2. E. M. Van Buskirk. Ophthalmology 87:447–450 (1980).

    PubMed  Google Scholar 

  3. J. L. Greaves. Ocular Drug Delivery. In C. G. Wilson, and N. Washington (eds.), Physiological Pharmaceutics—Biological Barriers to Drug Absorption. Ellis Horwood, New York, (1989).

    Google Scholar 

  4. T. J. Zimmerman, K. S. Kooner, A. S. Kandarakis, and L. P. Ziegler. Arch. Ophthalmol. 102:551–553 (1984).

    PubMed  Google Scholar 

  5. V. H. L. Lee and J. R. Robinson. J. Ocular Pharmacology 2(1):67–108 (1986).

    Google Scholar 

  6. B. Pech, O. Duval, P. Richomme, and J. P. Benoit. Int. J. Pharm. 128:179–188 (1996).

    Google Scholar 

  7. O. Vaisoglu and P. P. Speiser. Acta. Pharm. Suec. 23:163–172 (1986).

    PubMed  Google Scholar 

  8. B. Pech, P. Chetoni, M. F. Saettone, O. Duval, and J. P. Benoit. J. Ocular Pharmacology. 9:141–150 (1993).

    Google Scholar 

  9. A. D. Bangham, M. M. Standish and J. C. Watkins. J. Mol. Biol. 13:226–228 (1965).

    Google Scholar 

  10. J. T. Davies and E. K. Rideal. Surface chemistry: the physics of surfaces. Academic Press, New York, (1963).

    Google Scholar 

  11. H. Bundgaard, A. Buur, S-C. Chang, and V. H. L. Lee. Int. J. Pharm. 33:15–26 (1986).

    Google Scholar 

  12. J. Appell, G. Porte, A. Khatory, F. Kern, and S. J. Candau. J. Physique II France. 2:1045–1052 (1992).

    Google Scholar 

  13. A. Khatory, F. Kern, F. Lequeux, J. Appell, G. Porte, N. Morie, A. Ott, and W. Urbach. Langmuir. 9:933–939 (1993).

    Google Scholar 

  14. Z. Lin. Langmuir. 12:1729 (1996).

    Google Scholar 

  15. S. Engström, L. Lindahl, R. Wallin, and J. Engblom. Int. J. Pharm. 86:137–145 (1992).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pech, B., Proust, JE., Bouligand, Y. et al. Tensioactivity and Supramolecular Organization of the Palmitoyl Prodrug of Timolol. Pharm Res 14, 37–41 (1997). https://doi.org/10.1023/A:1012047231989

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012047231989

Navigation